Molecular Characterization and Clinical Impact of TMPRSS2-ERG Rearrangement on Prostate Cancer: Comparison between FISH and RT-PCR

Table 1

Demographics and main clinical and pathological features of the analyzed series.

Parameters	𝑛	%
PSA
<10 ng/mL	186	63.3
10–20 ng/mL	66	22.4
>20 ng/mL	42	14.3
Gleason-sp
≤6	118	40.1
7	139	47.3
8–10	37	12.6
cT
≤cT2b	273	92.9
≥cT3a	19	6.5
pT
≤pT2	160	54.4
≥pT3	133	45.2
pN*
pN0	190	64.6
pN ≥ 1	10	3.4
Perineural invasion
Negative	126	42.7
Positive	145	49.2

SP: specimen, cT: clinical stage, pT: pathological stage, PSA: prostatic-specific antigen, and pN: pathologic stage with respect to lymph node status.
∗Lymphadenectomy was limited to the obturator fossa in most of the cases at the inclusion period.